GHRP-6 (Growth Hormone Releasing Peptide-6) – 5 mg Vial + Sterile Water

Product Description:

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic peptide designed to stimulate the body’s natural growth hormone (GH) secretion while simultaneously increasing ghrelin levels, also known as the “hunger hormone.” Each pack contains 1 vial (5 mg) + sterile water for reconstitution.

GHRP-6 is widely used in bodybuilding and athletic performance for its ability to boost muscle growth, enhance recovery, stimulate appetite, and improve sleep quality.

Key Features

• Active Ingredient: GHRP-6 (Growth Hormone Releasing Peptide-6)
• Pack Size: 1 vial (5 mg) + sterile water
• Form: Injectable peptide (reconstituted before use)
• Category: Growth Hormone Releasing Peptide (GHRP)
• Purity: Lab-tested and pharma-grade, third-party verified

How GHRP-6 Works

• Stimulates the pituitary gland to release growth hormone
• Increases ghrelin levels, enhancing appetite and energy intake
• Promotes protein synthesis and cellular repair
• Improves sleep depth and recovery by influencing GH release
• Enhances lipolysis (fat metabolism), supporting leaner body composition

Uses & Benefits of GHRP-6

• Promotes muscle growth and recovery
• Enhances fat metabolism for better body composition
• Stimulates strong appetite response, making it ideal for bulking cycles
• Improves sleep quality and cellular repair
• Supports growth hormone and IGF-1 levels naturally

Dosage & Administration

• Typical Dosage: 100–300 mcg per injection
• Injection Frequency: 2–3 times daily (morning, post-workout, before bed)
• Cycle Duration: 4–12 weeks depending on goals
• Administration: Subcutaneous or intramuscular injection after reconstitution

Possible Side Effects of GHRP-6

While generally safe when used properly, some users may experience:

• Increased hunger (most common effect)
• Mild water retention
• Temporary flushing or tingling sensations
• Fluctuations in blood sugar levels

Who Should Avoid GHRP-6?

• Pregnant or breastfeeding women
• Individuals with pituitary disorders
• Cancer patients or those with tumor risk
• Users under 21 years of age